Furthermore, MM cells induce increased receptor activators of nuclear factor kappa B ligand (RANK-L) expression and inhibit production of its antagonist osteoprotegerin (OPG) by stromal cells, favouring osteoclast-mediated bone destruction [9,10]. Here, TNFRSF11B is linked to Miyoshi myopathy.